USMJ and PURA Majority Shareholder And Veteran CIA Operator Edward Bollen To Speak On Opioid Epidemic At SWCC
April 12 2017 - 8:38AM
InvestorsHub NewsWire
North American Cannabis Holdings, Inc. (USOTC:
USMJ) and Puration, Inc. (USOTC:
PURA) today announced that majority shareholder and
veteran Central Intelligence Agency (CIA) Operations Officer Edward
Bollen will speak at the upcoming Southwest Cannabis Conference and Expo (SWCC) in Fort
Worth, Texas April 22-23 on the subject of America’s current
opioid epidemic. Deaths from opioid overdoes are at an all
time high with 165,000 people dying form prescription opioid
overdoes alone since 1999. Cannabis provides a safe alternative to
many of the ailments treated with prescription opioids.
Mr. Bollen will participate in a panel discussion on the opioid
epidemic bringing his 33 years of U.S. Government service
experience in multiple National Security fields. Mr. Bollen
has extensive experience in military
special operations, law enforcement investigations and covert
action. He has traveled to, worked in or lived in over 70
different countries throughout his career. His career started
in the U.S. Marine Corps where his service included a 3-year tour
of duty as a military aid to the White House. Mr. Bollen
transitioned from the Marines to begin a 26 year career with the
Central Intelligence Agency (CIA) as an Intelligence Operations
Officer where he held several senior management positions both
domestic and abroad. He has served in Africa, the Middle East,
Central Eurasia, Asia, and South America.
In addition to his founding role at USMJ, Mr. Bollen works today as
a threat assessment
consultant, corporate security advisor and security team leader
for industrial physical and personal requirements. Mr. Bollen
recently worked as a consultant on the History Channel series “Selection:
Special Operations Experiment” which provided some unclassified insight into how
the America’s elite commands select candidates for service in
Special Forces units.
“I’m proud of the work USMJ has
accomplished in the evolving legal cannabis sector,” said Mr.
Bollen, majority shareholder and co-founder. “The company has
experimented and trialed a number of different enterprises across
this diverse and ever changing landscape. One can’t be an
entrepreneur in this market sector without also being a socially
responsible advocate for the real benefits cannabis has to bring to
the communality and economy. I believe you will find here at
USMJ that we are committed to doing our part, and we invite all to
come see for themselves at the Southwest Cannabis Conference and
Expo in Fort Worth next week.”
USMJ is presenting its fast casual
concept restaurant, the AmeriCanna Cafe, at the
Southwest Cannabis Conference and Expo and featuring its sports and
fitness nutritional supplement product line, EVERx with licensed
products produced by Puration to include EVERx CBD Infused Bottled
Sports Water, EVERx Alkaline Bottled Sports Water, and EVERx CBD
Infused Gummies for Post Workout Recovery.
Puration recently announced that NCM Biotech has licensed to PURA
the right to utilize NCM Biotech’s patented cannabis extraction
process to produce cannabis extracts for infusion into
recreational, fitness wellness, alternative medicine and beauty
products. NCM Biotech exclusively owns U.S. Patent No.
9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS
PLANT MATERIALS INCLUDING THE CANNABIS PLANT.” The
license of the process to PURA is the first and only license NCM
Biotech has executed. NCM and its founder Frederick Ferri
will also be at the Southwest Cannabis Conference and Expo.
Learn More About
USMJ:
growusmj.com
Learn More About
PURA:
purationinc.com
Disclaimer/Safe Harbor: This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies’ contracts, the companies’ liquidity
position, the companies’ ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
North American Cannabis Holdings Contact:
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024